Tender

NHS National Pharmaceuticals - Everolimus and terminated agreement products

NHS ENGLAND

This public procurement record has 1 release in its history.

Tender

09 Apr 2021 at 15:51

Summary of the contracting process

The NHS England is currently undertaking a tender for the provision of pharmaceuticals, specifically focusing on Everolimus and related products. This tender, identified as CM/PHG/21/5632, is classified under the pharmaceutical products category (CPV code 33600000) and is situated in various regions across the United Kingdom, including East Midlands, London, and the South West. The tender is at the planning stage, with the submission deadline set for 26th April 2021, at 13:00. The framework agreement's effective period will commence on 15th May 2021, with potential extensions of up to 24 months at the buyer's discretion.

This opportunity presents significant potential for business growth, particularly for suppliers specialising in pharmaceuticals and those with the capability to provide critical care medicines. Small and medium enterprises (SMEs) are encouraged to participate, given the open procurement method which aims to attract a wide range of applicants. Companies with experience in medical supplies, especially those familiar with frameworks for hospital products, oral medications, and pharmaceutical quality assessments, would be well-positioned to compete in this tender. With a total contract value of approximately £7.4 million, successful bidders can expect meaningful engagement with the NHS and the chance to contribute to critical healthcare sectors.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

NHS National Pharmaceuticals - Everolimus and terminated agreement products

Notice Description

Tender Close: 26th April, 13:00. Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement products Offer reference number: CM/PHG/21/5632 Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Potential periods of call-offs under the framework agreement: Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022 Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022 Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-a87524a8-9992-4a36-99de-0d633112b605
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/b7aad1a9-5aca-40f3-a4d7-5c1e65f5be1b
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£7,403,286 £1M-£10M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
9 Apr 20214 years ago
Submission Deadline
26 Apr 2021Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
14 May 2021 - 1 Mar 2022 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS ENGLAND
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Post Town
Warrington
Country
England

Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England)

Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-a87524a8-9992-4a36-99de-0d633112b605-2021-04-09T16:51:00+01:00",
    "date": "2021-04-09T16:51:00+01:00",
    "ocid": "ocds-b5fd17-a87524a8-9992-4a36-99de-0d633112b605",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "CF-0169000D0O000000rwimUAA1",
        "title": "NHS National Pharmaceuticals - Everolimus and terminated agreement products",
        "description": "Tender Close: 26th April, 13:00. Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement products Offer reference number: CM/PHG/21/5632 Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Potential periods of call-offs under the framework agreement: Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022 Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022 Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022",
        "datePublished": "2021-04-09T16:51:00+01:00",
        "status": "active",
        "classification": {
            "scheme": "CPV",
            "id": "33600000",
            "description": "Pharmaceutical products"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "postalCode": "WA7 2ES"
                    },
                    {
                        "region": "East Midlands",
                        "countryName": "United Kingdom"
                    },
                    {
                        "region": "East of England",
                        "countryName": "United Kingdom"
                    },
                    {
                        "region": "London",
                        "countryName": "United Kingdom"
                    },
                    {
                        "region": "North East",
                        "countryName": "United Kingdom"
                    },
                    {
                        "region": "North West",
                        "countryName": "United Kingdom"
                    },
                    {
                        "region": "South East",
                        "countryName": "United Kingdom"
                    },
                    {
                        "region": "South West",
                        "countryName": "United Kingdom"
                    },
                    {
                        "region": "West Midlands",
                        "countryName": "United Kingdom"
                    },
                    {
                        "region": "Yorkshire and the Humber",
                        "countryName": "United Kingdom"
                    },
                    {
                        "countryName": "Guernsey"
                    },
                    {
                        "countryName": "Jersey"
                    },
                    {
                        "countryName": "Isle of Man"
                    }
                ]
            }
        ],
        "value": {
            "amount": 7403286,
            "currency": "GBP"
        },
        "procurementMethod": "open",
        "procedure": {
            "isAccelerated": true,
            "acceleratedRationale": "This requirement to call for competition came about due to: i). the availability of competitive supply in circumstances relating to intellectual property rights that could not have been foreseen and/or acted upon by the authority using regular tender timescales, and ii). suppliers terminating existing agreements for critical care medicines where there remains an ongoing requirement to procure these medicines."
        },
        "procurementMethodDetails": "Open procedure (above threshold)",
        "tenderPeriod": {
            "endDate": "2021-04-26T13:00:00+01:00"
        },
        "contractPeriod": {
            "startDate": "2021-05-15T00:00:00+01:00",
            "endDate": "2022-03-01T23:59:59Z"
        },
        "suitability": {
            "sme": true,
            "vcse": false
        },
        "mainProcurementCategory": "goods",
        "documents": [
            {
                "id": "1",
                "documentType": "tenderNotice",
                "description": "Opportunity notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/b7aad1a9-5aca-40f3-a4d7-5c1e65f5be1b",
                "datePublished": "2021-04-09T16:51:00+01:00",
                "format": "text/html",
                "language": "en"
            },
            {
                "id": "2",
                "documentType": "Link",
                "description": "Document No. 00 - Read Me First Document - Everolimus",
                "url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLka/Q9R6UvHRLYxSRiKFFoAKGgv8t_vUHLtnAcPXCosQUlk"
            },
            {
                "id": "3",
                "documentType": "Link",
                "description": "Document No. 07a - Quality control technical sheet",
                "url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkz/df3zKmJ7mlf7AJof3o7ejJTpthwxvNpq8CoSxJrfMps"
            },
            {
                "id": "4",
                "documentType": "Link",
                "description": "Document No. 01 - Invitation to offer covering letter",
                "url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkf/aa.c0jLqkn7Jkm2Clt0rNVWe91LIVvPrm95J2v_0AUA"
            },
            {
                "id": "5",
                "documentType": "Link",
                "description": "Document No. 02 - Terms of offer",
                "url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkk/AqnLTNbSiXBuPLMNF1RmF2uUA6BMxQWjqjUtiz.IOz0"
            },
            {
                "id": "6",
                "documentType": "Link",
                "description": "Document No. 05a (v) Product Listing & Usage - Hospital Only Products CM_PHG_21_5632_02",
                "url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkh/N.ngD0FFcr2_.8o6ydbAPU5pjmYH6u_CDWslqNCp7fQ"
            },
            {
                "id": "7",
                "documentType": "Link",
                "description": "Document No. 05b - Selectt offer schedule instructions",
                "url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLku/NXDYgLz3iwb6gBxsCBRIqaMwN7TMtKDER0Xr9t1BOaE"
            },
            {
                "id": "8",
                "documentType": "Link",
                "description": "Document No. 03 - Framework Agreement and Terms and Conditions",
                "url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkp/ah6w_KrHQyhJsXTkdfzKJLkE556DYVR.BCeHDSyYunA"
            },
            {
                "id": "9",
                "documentType": "Link",
                "description": "Document No. 04 - Contract technical specification",
                "url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkl/OpfXYhW0hFEHSZNuvsKHP1Y2PKDRvT03X3uYVa8fXgI"
            },
            {
                "id": "10",
                "documentType": "Link",
                "description": "Document No. 05a (ii), 05a (iv), 05a (vi) CM_PHG_21_5632 SELECTT Application",
                "url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkg/khmtJiVSTjD9NfUPJBstfaF5ssV_PbrLx7lO7AGEhjo"
            },
            {
                "id": "11",
                "documentType": "Link",
                "description": "Document No. 05a (i) Product Listing & Usage - Everolimus CM_PHG_21_5632_00",
                "url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkm/qbdByrJNHur91cEbIjwAwKkHpNPKQJVhtgfrMAfkXfs"
            },
            {
                "id": "12",
                "documentType": "Link",
                "description": "Document No. 05a (iii) Product Listing & Usage - Oral (plus non-parenteral) products CM_PHG_21_5632_01",
                "url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkn/3Uqdn9uozzwdz77pQ9x6MbwYJ3O8ShE0yzFY25K2N.M"
            },
            {
                "id": "13",
                "documentType": "Link",
                "description": "Document No. 08 - Confidential information schedule",
                "url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLl4/oLiz.eGY8KAak1HgYLIbVEIVH80KPHZyfyIT1EzbJmo"
            },
            {
                "id": "14",
                "documentType": "Link",
                "description": "FTS Notice - NHS National Pharmaceuticals - Everolimus and terminated agreement products",
                "url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLl5/4C4KS_U1lHnBEKe8mIa20v3AOvNKEiuEgJGeTXr8A.s"
            },
            {
                "id": "15",
                "documentType": "Link",
                "description": "Document No. 06 - Form of offer",
                "url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkb/d.hnrkbP90kLLalIRykdP9rRZ7r1wNiRi_UosE9Phs4"
            },
            {
                "id": "16",
                "documentType": "Link",
                "description": "Document No. 07b - Guidance for Performing a Pharmaceutical Quality Assessment of Licensed Medicines for the NHS",
                "url": "https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLko/vFBvJs87O6C6bId1CEx6Y8xIErG7bfdqJChOdiUF8bA"
            }
        ]
    },
    "parties": [
        {
            "id": "GB-CFS-156282",
            "name": "NHS England",
            "identifier": {
                "legalName": "NHS England"
            },
            "address": {
                "streetAddress": "2nd Floor Rutland House",
                "locality": "Runcorn",
                "postalCode": "WA7 2ES",
                "countryName": "UK"
            },
            "contactPoint": {
                "name": "Gemma Tomlinson",
                "email": "gemma.tomlinson1@nhs.net"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-156282",
        "name": "NHS England"
    }
}